共 50 条
[42]
Outcomes for Elderly Ovarian Cancer Patients Treated with Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)
[J].
Annals of Surgical Oncology,
2021, 28
:4655-4666
[46]
Predictors of Financial Toxicity Risk Among Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS–HIPEC)
[J].
Annals of Surgical Oncology,
2024, 31
:1980-1989